2026年正子斷層掃描（PET）放射性追蹤劑全球市場報告

近年來，正子斷層掃描（PET）放射性追蹤劑市場成長顯著，預計將以9.2%的複合年成長率成長，從2025年的25.4億美元成長到2026年的27.8億美元。過去幾年的成長可歸因於癌症診斷率的提高、核醫設施的擴建、基於FDG的影像診斷的建立、迴旋加速器基礎設施的發展以及診斷影像服務的擴展等因素。

預計未來幾年正子斷層掃描（PET）放射性追蹤劑市場將強勁成長，2030年市場規模將達39.5億美元，複合年成長率（CAGR）為9.2%。預測期內的成長要素包括：對精準診斷的需求不斷成長、放射性藥物治療診斷學投入增加、診療一體化應用範圍擴大、PET影像在神經病學和心臟病學領域的應用日益廣泛，以及新型示踪劑獲得監管部門核准的增多。預測期內的主要趨勢包括：靶向特異性放射性示踪劑的研發不斷推進、PET成像在腫瘤診斷領域的應用日益廣泛、FDG以外的新型同位素的應用不斷擴展、個性化核醫學的應用日益增多，以及對短半衰期放射性示踪劑生產的日益重視。

預計未來幾年，感染疾病的日益普及將推動正子斷層掃描（PET）放射性追蹤劑市場的成長。感染疾病是由致病微生物（例如細菌、病毒、真菌和寄生蟲）引起的疾病。這些疾病的增加歸因於氣候變遷、都市化、全球化、抗生素抗藥性和人類行為改變等因素，所有這些因素都促進了病原體的傳播。 PET放射性追蹤劑透過可視化代謝活動和炎症，有助於感染疾病的管理，從而促進感染的檢測、治療效果的評估以及感染疾病和非感染疾病的鑑別，進而改善患者的治療效果。例如，根據英國英國機構衛生安全局（Health Security）於2024年2月發布的報告，英格蘭的結核病（TB）病例數將在2023年增加10.7%，達到4850例（高於2022年的4,380例）。因此，感染疾病負擔的加重促進了PET放射性示蹤劑市場的擴張。

正子斷層掃描 (PET) 放射性追蹤劑市場的企業致力於開發先進的診斷解決方案，包括 PET 造影劑，旨在提高癌症檢出率並改善患者預後。 PET 造影劑是一種放射性物質，可在 PET 掃描過程中對體內生物過程進行視覺化和定量分析。例如，2023 年 3 月，總部位於加拿大的放射性藥物公司 IsoLogic Innovative Radiopharmaceuticals 在加拿大推出了 Illuccix（也稱為 Ga-68 Gozetotide 製備試劑盒 (PSMA-11)）。這種前列腺癌影像劑旨在檢測轉移性前列腺癌，幫助醫生識別轉移性疾病並指導患者治療決策。此藥物適用於疑似轉移且符合初始根治性治療條件的患者，以及根據血清前列腺特異性抗原 (PSA) 水平升高而懷疑復發的患者。

目錄

第1章執行摘要

第2章 市場特徵

• 市場定義和範圍
• 市場區隔
• 主要產品和服務概述
• 全球正子斷層掃描（PET）放射性示蹤劑市場：吸引力評分及分析
• 成長潛力分析、競爭評估、策略契合度評估、風險狀況評估

第3章 市場供應鏈分析

• 供應鏈與生態系概述
• 主要原料、資源和供應商清單
• 主要經銷商和通路合作夥伴名單
• 主要最終用戶列表

第4章 全球市場趨勢與策略

• 關鍵技術和未來趨勢
  • 生物技術、基因組學和精準醫學
  • 工業4.0和智慧製造
  • 數位化、雲端運算、巨量資料、網路安全
  • 永續性、氣候技術和循環經濟
  • 人工智慧（AI）和自主人工智慧
• 主要趨勢
  • 標靶特異性放射性示蹤劑的研發不斷推進
  • PET影像在腫瘤診斷的應用日益廣泛
  • 擴大除FDG以外的新同位素的使用範圍
  • 擴大個人化核子醫學的應用
  • 更重視生產短壽命放射性示蹤劑

第5章 終端用戶產業市場分析

• 醫院
• 診斷中心
• 核子醫學診所
• 研究所
• 癌症治療中心

第6章 市場：宏觀經濟情景，包括利率、通貨膨脹、地緣政治、貿易戰和關稅的影響、關稅戰和貿易保護主義對供應鏈的影響，以及新冠疫情對市場的影響

第7章 全球策略分析架構、目前市場規模、市場對比及成長率分析

• 全球正子斷層掃描（PET）放射性追蹤劑市場：PESTEL分析（政治、社會、技術、環境、法律因素、促進因素與限制因素）
• 全球正子斷層掃描（PET）放射性示蹤劑市場規模、對比及成長率分析
• 全球正子斷層掃描（PET）放射性示蹤劑市場表現：規模與成長，2020-2025年
• 全球正子斷層掃描（PET）放射性示蹤劑市場預測：規模與成長，2025-2030年，2035年預測

第8章 全球潛在市場規模（TAM）

第9章 市場細分

• 按放射性示踪劑的類型
• F-18（氟代脫氧葡萄糖-18）、Ga-68（纖維母細胞活化蛋白抑制劑）和其他類型的放射性追蹤劑
• 透過使用
• 癌症、心臟病、消化器官系統、內分泌系統疾病、神經系統疾病及其他適應症
• 最終用戶
• 醫院、診斷中心和其他最終用戶
• 按類型細分：F-18（氟代脫氧葡萄糖 18）
• F-18 FDG（氟代脫氧葡萄糖）、F-18 氟乙基酪胺酸（FET）、F-18 氟貝他吡（澱粉樣蛋白 PET 影像）
• 按類型細分：Ga-68（纖維母細胞活化蛋白抑制劑）
• Ga-68 dotatate（神經內分泌腫瘤顯像）、Ga-68 PSMA（前列腺特異性膜抗原顯像）、Ga-68 FAPI（纖維母細胞活化蛋白抑制劑顯像）
• 按類型細分：其他放射性示踪劑類型
• C-11（碳11）、N-13（氮13）、O-15（氧15）、Rb-82（銣82）、I-124（碘124）

第10章 區域與國家分析

• 全球正子斷層掃描（PET）放射性追蹤劑市場：區域分析、預測（2020-2025年、2025-2030年預測、2035年預測）
• 全球正子斷層掃描（PET）放射性示蹤劑市場：按國家/地區、性能和預測分類，2020-2025年、2025-2030年預測、2035年預測

第11章 亞太市場

第12章：中國市場

第13章 印度市場

第14章 日本市場

第15章：澳洲市場

第16章 印尼市場

第17章 韓國市場

第18章 台灣市場

第19章 東南亞市場

第20章：西歐市場

第21章英國市場

第22章 德國市場

第23章：法國市場

第24章：義大利市場

第25章：西班牙市場

第26章 東歐市場

第27章：俄羅斯市場

第28章 北美市場

第29章：美國市場

第30章：加拿大市場

第31章 南美洲市場

第32章：巴西市場

第33章 中東市場

第34章：非洲市場

第35章 市場監理與投資環境

第36章：競爭格局與公司概況

• 正子斷層掃描（PET）放射性追蹤劑市場：競爭格局與市場佔有率，2024年
• 正子斷層掃描（PET）放射性示蹤劑市場：公司估價矩陣
• 正子斷層掃描（PET）放射性示蹤劑市場：公司概況
  • Cardinal Health Inc.
  • GE Healthcare Technologies Inc.
  • Bracco Imaging SpA
  • Lantheus Holdings Inc.
  • Jubilant Pharma Limited

第37章：其他領先和創新企業

• SOFIE Biosciences, Yantai Dongcheng Pharmaceutical Group Co. Ltd., Nordion Inc., Isologic Innovative Radiopharmaceuticals, ABX Advanced Biochemical Compounds GmbH, IBA Radiopharma Solutions SA, ImaginAb Inc., Radiomedix Inc., Curium Pharma, Blue Earth Diagnostics Ltd., Eckert & Ziegler Radiopharma GmbH, Advanced Accelerator Applications（Novartis）, Telix Pharmaceuticals Limited, PETNET Solutions Inc., Piramal Imaging

第38章：全球市場競爭基準分析與儀錶板

第39章 重大併購

第40章：高潛力市場國家、細分市場與策略

• 2030年正子斷層掃描（PET）放射性追蹤劑市場：提供新機會的國家
• 2030年正子斷層掃描（PET）放射性追蹤劑市場：提供新機會的細分市場
• 2030年正子斷層掃描（PET）放射性追蹤劑市場：成長策略
  • 基於市場趨勢的策略
  • 競爭對手策略

第41章附錄

A positron emission tomography (PET) radiotracer is a radioactive substance used in PET imaging. This radiotracer is administered to a patient via injection, where it binds to specific biological targets, enabling the PET scanner to visualize metabolic activity and diagnose conditions such as cancer or neurological disorders.

The primary types of PET radiotracers include F-18 (Fluorodeoxyglucose 18), Ga-68 (Fibroblast Activation Protein Inhibitor), and others. F-18 (Fluorodeoxyglucose 18) radiotracers are radioactive glucose analogs utilized in PET imaging to evaluate metabolic activity in tissues, particularly for cancer detection. These radiotracers are applied across various medical fields, including oncology, cardiology, gastrointestinal disorders, endocrine issues, and neurology. They are used by end-users such as hospitals and diagnostic centers, among others.

Tariffs are impacting the PET radiotracer market by increasing costs of imported radioisotopes, synthesis modules, cyclotron components, and quality control equipment. Hospitals and diagnostic centers in North America and Europe are most affected due to dependence on imported isotopes and production technologies, while Asia-Pacific faces higher manufacturing input costs. These tariffs are increasing operational expenses and affecting tracer availability. However, they are also encouraging domestic isotope production, regional radiopharmacy expansion, and localized supply chain development.

The positron emission tomography (pet) radiotracer market research report is one of a series of new reports from The Business Research Company that provides positron emission tomography (pet) radiotracer market statistics, including positron emission tomography (pet) radiotracer industry global market size, regional shares, competitors with a positron emission tomography (pet) radiotracer market share, detailed positron emission tomography (pet) radiotracer market segments, market trends and opportunities, and any further data you may need to thrive in the positron emission tomography (pet) radiotracer industry. This positron emission tomography (pet) radiotracer market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The positron emission tomography (pet) radiotracer market size has grown strongly in recent years. It will grow from $2.54 billion in 2025 to $2.78 billion in 2026 at a compound annual growth rate (CAGR) of 9.2%. The growth in the historic period can be attributed to increasing cancer diagnosis rates, expansion of nuclear medicine facilities, established use of fdg-based imaging, availability of cyclotron infrastructure, growth of diagnostic imaging services.

The positron emission tomography (pet) radiotracer market size is expected to see strong growth in the next few years. It will grow to $3.95 billion in 2030 at a compound annual growth rate (CAGR) of 9.2%. The growth in the forecast period can be attributed to increasing demand for precision diagnostics, rising investments in radiopharmaceutical R&D, expansion of theranostics applications, growing adoption of pet imaging in neurology and cardiology, increasing regulatory approvals for new tracers. Major trends in the forecast period include increasing development of target-specific radiotracers, rising adoption of pet imaging in oncology diagnostics, growing use of novel isotopes beyond fdg, expansion of personalized nuclear medicine applications, enhanced focus on short-half-life radiotracer production.

The rising prevalence of infectious diseases is expected to drive the growth of the positron emission tomography (PET) radiotracer market in the coming years. Infectious diseases are illnesses caused by pathogenic microorganisms, including bacteria, viruses, fungi, and parasites. The increasing occurrence of these diseases is attributed to factors such as climate change, urbanization, globalization, antibiotic resistance, and shifts in human behavior, all of which contribute to the spread of pathogens. PET radiotracers support the management of infectious diseases by enabling visualization of metabolic activity and inflammation, facilitating infection detection, evaluation of treatment response, and differentiation between infectious and non-infectious conditions, thereby improving patient outcomes. For example, in February 2024, a report published by the UK Health Security Agency, a UK-based government organization, indicated that tuberculosis (TB) cases in England rose by 10.7% in 2023, with 4,850 cases reported compared to 4,380 cases in 2022. Consequently, the growing burden of infectious diseases is contributing to the expansion of the PET radiotracer market.

Companies active in the positron emission tomography (PET) radiotracer market are increasingly focusing on the development of advanced diagnostic solutions, including PET imaging agents, to improve cancer detection and patient outcomes. PET imaging agents are radioactive substances used to visualize and quantify biological processes within the body during PET scans. For instance, in March 2023, IsoLogic Innovative Radiopharmaceuticals, a Canada-based radiopharmaceutical company, launched Illuccix, also referred to as the Ga-68 Gozetotide Preparation Kit (PSMA-11), in Canada. This prostate cancer imaging agent is designed to detect metastatic prostate cancer and supports physicians in identifying metastatic disease and guiding patient management decisions. It is indicated for use in patients suspected of having metastasis who are candidates for initial definitive therapy, as well as in individuals with suspected recurrence based on elevated serum prostate-specific antigen (PSA) levels.

In February 2023, Lantheus Holdings Inc., a US-based developer of diagnostic products, acquired Cerveau Technologies for an undisclosed amount. This acquisition is intended to strengthen Lantheus Holdings' imaging pipeline, particularly in the area of Alzheimer's disease diagnostics, by integrating Cerveau's MK-6240, a second-generation PET imaging agent that targets tau tangles in the brain. Cerveau Technologies Inc. is a US-based company involved in the development of positron emission tomography (PET) radiotracers.

Major companies operating in the positron emission tomography (pet) radiotracer market are Cardinal Health Inc., GE Healthcare Technologies Inc., Bracco Imaging S.p.A., Lantheus Holdings Inc., Jubilant Pharma Limited, SOFIE Biosciences, Yantai Dongcheng Pharmaceutical Group Co. Ltd., Nordion Inc., Isologic Innovative Radiopharmaceuticals, ABX Advanced Biochemical Compounds GmbH, IBA Radiopharma Solutions S.A., ImaginAb Inc., Radiomedix Inc., Curium Pharma, Blue Earth Diagnostics Ltd., Eckert & Ziegler Radiopharma GmbH, Advanced Accelerator Applications (Novartis), Telix Pharmaceuticals Limited, PETNET Solutions Inc., Piramal Imaging

North America was the largest region in the positron emission tomography (PET) radiotracer market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the positron emission tomography (pet) radiotracer market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the positron emission tomography (pet) radiotracer market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The positron emission tomography (PET) radiotracer market consists of sales of FDG (fluorodeoxyglucose), f-dopa (fluorodopa), C-11 methionine, C-11 methionine, F-18 naf (sodium fluoride), and C-11 choline. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Positron Emission Tomography (PET) Radiotracer Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses positron emission tomography (pet) radiotracer market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on end user analysis.
• Benchmark performance against key competitors based on market share, innovation, and brand strength.
• Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
• Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for positron emission tomography (pet) radiotracer ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The positron emission tomography (pet) radiotracer market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
• The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
• The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
• The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
• The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
• The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

• Markets Covered:1) By Radiotracer Type: F-18 (Fluorodeoxyglucose 18); Ga-68 (Fibroblast Activation Protein Inhibitor); Other Radiotracer Types
• 2) By Application: Cancer; Heart Disease; Gastrointestinal; Endocrine; Neurological Disorders; Other Applications
• 3) By End-User: Hospitals; Diagnostic Centers; Other End-Users
• Subsegments:
• 1) By F-18 (Fluorodeoxyglucose 18): F-18 FDG (Fluorodeoxyglucose); F-18 Fluoroethyltyrosine (FET); F-18 Florbetapir (Amyloid PET Imaging)
• 2) By Ga-68 (Fibroblast Activation Protein Inhibitor): Ga-68 Dotatate (Neuroendocrine Tumor Imaging); Ga-68 PSMA (Prostate-Specific Membrane Antigen Imaging); Ga-68 FAPI (Fibroblast Activation Protein Inhibitor Imaging)
• 3) By Other Radiotracer Types: C-11 (Carbon-11); N-13 (Nitrogen-13); O-15 (Oxygen-15); Rb-82 (Rubidium-82); I-124 (Iodine-124)
• Companies Mentioned: Cardinal Health Inc.; GE Healthcare Technologies Inc.; Bracco Imaging S.p.A.; Lantheus Holdings Inc.; Jubilant Pharma Limited; SOFIE Biosciences; Yantai Dongcheng Pharmaceutical Group Co. Ltd.; Nordion Inc.; Isologic Innovative Radiopharmaceuticals; ABX Advanced Biochemical Compounds GmbH; IBA Radiopharma Solutions S.A.; ImaginAb Inc.; Radiomedix Inc.; Curium Pharma; Blue Earth Diagnostics Ltd.; Eckert & Ziegler Radiopharma GmbH; Advanced Accelerator Applications (Novartis); Telix Pharmaceuticals Limited; PETNET Solutions Inc.; Piramal Imaging
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: Word, PDF or Interactive Report
• + Excel Dashboard
• Added Benefits
• Bi-Annual Data Update
• Customisation
• Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

• 1.1. Key Market Insights (2020-2035)
• 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
• 1.3. Major Factors Driving the Market
• 1.4. Top Three Trends Shaping the Market

2. Positron Emission Tomography (PET) Radiotracer Market Characteristics

• 2.1. Market Definition & Scope
• 2.2. Market Segmentations
• 2.3. Overview of Key Products and Services
• 2.4. Global Positron Emission Tomography (PET) Radiotracer Market Attractiveness Scoring And Analysis
  • 2.4.1. Overview of Market Attractiveness Framework
  • 2.4.2. Quantitative Scoring Methodology
  • 2.4.3. Factor-Wise Evaluation
• Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
• 2.4.4. Market Attractiveness Scoring and Interpretation
• 2.4.5. Strategic Implications and Recommendations

3. Positron Emission Tomography (PET) Radiotracer Market Supply Chain Analysis

• 3.1. Overview of the Supply Chain and Ecosystem
• 3.2. List Of Key Raw Materials, Resources & Suppliers
• 3.3. List Of Major Distributors and Channel Partners
• 3.4. List Of Major End Users

4. Global Positron Emission Tomography (PET) Radiotracer Market Trends And Strategies

• 4.1. Key Technologies & Future Trends
  • 4.1.1 Biotechnology, Genomics & Precision Medicine
  • 4.1.2 Industry 4.0 & Intelligent Manufacturing
  • 4.1.3 Digitalization, Cloud, Big Data & Cybersecurity
  • 4.1.4 Sustainability, Climate Tech & Circular Economy
  • 4.1.5 Artificial Intelligence & Autonomous Intelligence
• 4.2. Major Trends
  • 4.2.1 Increasing Development Of Target-Specific Radiotracers
  • 4.2.2 Rising Adoption Of Pet Imaging In Oncology Diagnostics
  • 4.2.3 Growing Use Of Novel Isotopes Beyond Fdg
  • 4.2.4 Expansion Of Personalized Nuclear Medicine Applications
  • 4.2.5 Enhanced Focus On Short-Half-Life Radiotracer Production

5. Positron Emission Tomography (PET) Radiotracer Market Analysis Of End Use Industries

• 5.1 Hospitals
• 5.2 Diagnostic Centers
• 5.3 Nuclear Medicine Clinics
• 5.4 Research Institutes
• 5.5 Cancer Treatment Centers

6. Positron Emission Tomography (PET) Radiotracer Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Positron Emission Tomography (PET) Radiotracer Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

• 7.1. Global Positron Emission Tomography (PET) Radiotracer PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 7.2. Global Positron Emission Tomography (PET) Radiotracer Market Size, Comparisons And Growth Rate Analysis
• 7.3. Global Positron Emission Tomography (PET) Radiotracer Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
• 7.4. Global Positron Emission Tomography (PET) Radiotracer Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Positron Emission Tomography (PET) Radiotracer Total Addressable Market (TAM) Analysis for the Market

• 8.1. Definition and Scope of Total Addressable Market (TAM)
• 8.2. Methodology and Assumptions
• 8.3. Global Total Addressable Market (TAM) Estimation
• 8.4. TAM vs. Current Market Size Analysis
• 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Positron Emission Tomography (PET) Radiotracer Market Segmentation

• 9.1. Global Positron Emission Tomography (PET) Radiotracer Market, Segmentation By Radiotracer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• F-18 (Fluorodeoxyglucose 18), Ga-68 (Fibroblast Activation Protein Inhibitor), Other Radiotracer Types
• 9.2. Global Positron Emission Tomography (PET) Radiotracer Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Cancer, Heart Disease, Gastrointestinal, Endocrine, Neurological Disorders, Other Applications
• 9.3. Global Positron Emission Tomography (PET) Radiotracer Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Hospitals, Diagnostic Centers, Other End-Users
• 9.4. Global Positron Emission Tomography (PET) Radiotracer Market, Sub-Segmentation Of F-18 (Fluorodeoxyglucose 18), By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• F-18 FDG (Fluorodeoxyglucose), F-18 Fluoroethyltyrosine (FET), F-18 Florbetapir (Amyloid PET Imaging)
• 9.5. Global Positron Emission Tomography (PET) Radiotracer Market, Sub-Segmentation Of Ga-68 (Fibroblast Activation Protein Inhibitor), By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Ga-68 Dotatate (Neuroendocrine Tumor Imaging), Ga-68 PSMA (Prostate-Specific Membrane Antigen Imaging), Ga-68 FAPI (Fibroblast Activation Protein Inhibitor Imaging)
• 9.6. Global Positron Emission Tomography (PET) Radiotracer Market, Sub-Segmentation Of Other Radiotracer Types, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• C-11 (Carbon-11), N-13 (Nitrogen-13), O-15 (Oxygen-15), Rb-82 (Rubidium-82), I-124 (Iodine-124)

10. Positron Emission Tomography (PET) Radiotracer Market Regional And Country Analysis

• 10.1. Global Positron Emission Tomography (PET) Radiotracer Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• 10.2. Global Positron Emission Tomography (PET) Radiotracer Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Positron Emission Tomography (PET) Radiotracer Market

• 11.1. Asia-Pacific Positron Emission Tomography (PET) Radiotracer Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 11.2. Asia-Pacific Positron Emission Tomography (PET) Radiotracer Market, Segmentation By Radiotracer Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Positron Emission Tomography (PET) Radiotracer Market

• 12.1. China Positron Emission Tomography (PET) Radiotracer Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 12.2. China Positron Emission Tomography (PET) Radiotracer Market, Segmentation By Radiotracer Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Positron Emission Tomography (PET) Radiotracer Market

• 13.1. India Positron Emission Tomography (PET) Radiotracer Market, Segmentation By Radiotracer Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Positron Emission Tomography (PET) Radiotracer Market

• 14.1. Japan Positron Emission Tomography (PET) Radiotracer Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 14.2. Japan Positron Emission Tomography (PET) Radiotracer Market, Segmentation By Radiotracer Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Positron Emission Tomography (PET) Radiotracer Market

• 15.1. Australia Positron Emission Tomography (PET) Radiotracer Market, Segmentation By Radiotracer Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Positron Emission Tomography (PET) Radiotracer Market

• 16.1. Indonesia Positron Emission Tomography (PET) Radiotracer Market, Segmentation By Radiotracer Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Positron Emission Tomography (PET) Radiotracer Market

• 17.1. South Korea Positron Emission Tomography (PET) Radiotracer Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 17.2. South Korea Positron Emission Tomography (PET) Radiotracer Market, Segmentation By Radiotracer Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Positron Emission Tomography (PET) Radiotracer Market

• 18.1. Taiwan Positron Emission Tomography (PET) Radiotracer Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 18.2. Taiwan Positron Emission Tomography (PET) Radiotracer Market, Segmentation By Radiotracer Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Positron Emission Tomography (PET) Radiotracer Market

• 19.1. South East Asia Positron Emission Tomography (PET) Radiotracer Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 19.2. South East Asia Positron Emission Tomography (PET) Radiotracer Market, Segmentation By Radiotracer Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Positron Emission Tomography (PET) Radiotracer Market

• 20.1. Western Europe Positron Emission Tomography (PET) Radiotracer Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 20.2. Western Europe Positron Emission Tomography (PET) Radiotracer Market, Segmentation By Radiotracer Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Positron Emission Tomography (PET) Radiotracer Market

• 21.1. UK Positron Emission Tomography (PET) Radiotracer Market, Segmentation By Radiotracer Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Positron Emission Tomography (PET) Radiotracer Market

• 22.1. Germany Positron Emission Tomography (PET) Radiotracer Market, Segmentation By Radiotracer Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Positron Emission Tomography (PET) Radiotracer Market

• 23.1. France Positron Emission Tomography (PET) Radiotracer Market, Segmentation By Radiotracer Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Positron Emission Tomography (PET) Radiotracer Market

• 24.1. Italy Positron Emission Tomography (PET) Radiotracer Market, Segmentation By Radiotracer Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Positron Emission Tomography (PET) Radiotracer Market

• 25.1. Spain Positron Emission Tomography (PET) Radiotracer Market, Segmentation By Radiotracer Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Positron Emission Tomography (PET) Radiotracer Market

• 26.1. Eastern Europe Positron Emission Tomography (PET) Radiotracer Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 26.2. Eastern Europe Positron Emission Tomography (PET) Radiotracer Market, Segmentation By Radiotracer Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Positron Emission Tomography (PET) Radiotracer Market

• 27.1. Russia Positron Emission Tomography (PET) Radiotracer Market, Segmentation By Radiotracer Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Positron Emission Tomography (PET) Radiotracer Market

• 28.1. North America Positron Emission Tomography (PET) Radiotracer Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 28.2. North America Positron Emission Tomography (PET) Radiotracer Market, Segmentation By Radiotracer Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Positron Emission Tomography (PET) Radiotracer Market

• 29.1. USA Positron Emission Tomography (PET) Radiotracer Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 29.2. USA Positron Emission Tomography (PET) Radiotracer Market, Segmentation By Radiotracer Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Positron Emission Tomography (PET) Radiotracer Market

• 30.1. Canada Positron Emission Tomography (PET) Radiotracer Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 30.2. Canada Positron Emission Tomography (PET) Radiotracer Market, Segmentation By Radiotracer Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Positron Emission Tomography (PET) Radiotracer Market

• 31.1. South America Positron Emission Tomography (PET) Radiotracer Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 31.2. South America Positron Emission Tomography (PET) Radiotracer Market, Segmentation By Radiotracer Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Positron Emission Tomography (PET) Radiotracer Market

• 32.1. Brazil Positron Emission Tomography (PET) Radiotracer Market, Segmentation By Radiotracer Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Positron Emission Tomography (PET) Radiotracer Market

• 33.1. Middle East Positron Emission Tomography (PET) Radiotracer Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 33.2. Middle East Positron Emission Tomography (PET) Radiotracer Market, Segmentation By Radiotracer Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Positron Emission Tomography (PET) Radiotracer Market

• 34.1. Africa Positron Emission Tomography (PET) Radiotracer Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 34.2. Africa Positron Emission Tomography (PET) Radiotracer Market, Segmentation By Radiotracer Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Positron Emission Tomography (PET) Radiotracer Market Regulatory and Investment Landscape

36. Positron Emission Tomography (PET) Radiotracer Market Competitive Landscape And Company Profiles

• 36.1. Positron Emission Tomography (PET) Radiotracer Market Competitive Landscape And Market Share 2024
  • 36.1.1. Top 10 Companies (Ranked by revenue/share)
• 36.2. Positron Emission Tomography (PET) Radiotracer Market - Company Scoring Matrix
  • 36.2.1. Market Revenues
  • 36.2.2. Product Innovation Score
  • 36.2.3. Brand Recognition
• 36.3. Positron Emission Tomography (PET) Radiotracer Market Company Profiles
  • 36.3.1. Cardinal Health Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.2. GE Healthcare Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.3. Bracco Imaging S.p.A. Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.4. Lantheus Holdings Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.5. Jubilant Pharma Limited Overview, Products and Services, Strategy and Financial Analysis

37. Positron Emission Tomography (PET) Radiotracer Market Other Major And Innovative Companies

• SOFIE Biosciences, Yantai Dongcheng Pharmaceutical Group Co. Ltd., Nordion Inc., Isologic Innovative Radiopharmaceuticals, ABX Advanced Biochemical Compounds GmbH, IBA Radiopharma Solutions S.A., ImaginAb Inc., Radiomedix Inc., Curium Pharma, Blue Earth Diagnostics Ltd., Eckert & Ziegler Radiopharma GmbH, Advanced Accelerator Applications (Novartis), Telix Pharmaceuticals Limited, PETNET Solutions Inc., Piramal Imaging

38. Global Positron Emission Tomography (PET) Radiotracer Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Positron Emission Tomography (PET) Radiotracer Market

40. Positron Emission Tomography (PET) Radiotracer Market High Potential Countries, Segments and Strategies

• 40.1 Positron Emission Tomography (PET) Radiotracer Market In 2030 - Countries Offering Most New Opportunities
• 40.2 Positron Emission Tomography (PET) Radiotracer Market In 2030 - Segments Offering Most New Opportunities
• 40.3 Positron Emission Tomography (PET) Radiotracer Market In 2030 - Growth Strategies
  • 40.3.1 Market Trend Based Strategies
  • 40.3.2 Competitor Strategies

41. Appendix

• 41.1. Abbreviations
• 41.2. Currencies
• 41.3. Historic And Forecast Inflation Rates
• 41.4. Research Inquiries
• 41.5. The Business Research Company
• 41.6. Copyright And Disclaimer